HEALTH PROFESSIONALS' KNOWLEDGE ABOUT THE USE OF PREP IN THE STATE OF SERGIPE

Abstract

HIV, or the human immunodeficiency virus, is responsible for AIDS and attacks the immune system, particularly CD4+ T lymphocytes. In 2018, PrEP (pre-exposure prophylaxis) was introduced—a combination of medications (tenofovir and emtricitabine) that blocks HIV infection. It is effective for high-risk individuals, such as men who have sex with men, transgender people, and sex workers. PrEP is provided free of charge by the SUS (Brazilian public health system), but its prescription by healthcare professionals is limited due to a lack of knowledge and practice. This study aims to assess healthcare professionals' knowledge of PrEP recommendations, emphasizing the importance of adherence and effective communication in HIV prevention. The research was conducted with doctors, nurses, and pharmacists in the state of Sergipe during September and October 2024. OBJECTIVE: To assess healthcare professionals' knowledge of PrEP use in the state of Sergipe. METHODS: The research was conducted using a data collection tool consisting of a series of questions, answered online without an interviewer. The questionnaire was applied through Google Forms, a digital tool that allows for maximum participation across the state of Sergipe. RESULTS: A total of 54 professionals participated in the survey. Of these, 96.3% had heard of PrEP; however, 61.1% reported not having enough knowledge to prescribe it, and 81.1% stated that they needed training to perform the prescription. CONCLUSION: According to the participants' responses, many professionals are aware of what PrEP is but do not feel prepared to recommend it due to a lack of knowledge about the drugs used and the necessary training for their proper application and potential adverse reactions.